Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mark Alan Little

Showing results (1-10 of 3) with videos related to

Pageof 1
Sort By:
Rheumatology (Oxford, England)|May 15, 2018
Releasing the complement brakes: is myeloperoxidase the missing link between factor H and C5a in anti-neutrophil cytoplasmic antibody vasculitis?Peter Heeringa, Mark Alan Little
Kidney International|August 16, 2017
ANCA in anti-GBM disease: moving beyond a one-dimensional clinical phenotypeMark Canney, Mark Alan Little
Renal Failure|January 19, 2012
Fortuitous vasculitisHema Sharma, Ashvini Keshavan, Mark Alan Little, et al.
Pageof 1

Showing results (1-10 of 3) with videos related to

Sort By:
Pageof 1
Rheumatology (Oxford, England)|May 15, 2018
Releasing the complement brakes: is myeloperoxidase the missing link between factor H and C5a in anti-neutrophil cytoplasmic antibody vasculitis?Peter Heeringa, Mark Alan Little
Kidney International|August 16, 2017
ANCA in anti-GBM disease: moving beyond a one-dimensional clinical phenotypeMark Canney, Mark Alan Little
Renal Failure|January 19, 2012
Fortuitous vasculitisHema Sharma, Ashvini Keshavan, Mark Alan Little, et al.
Pageof 1